01
Clinical question
Muscle activity, volume, skin quality, local fat, scar and striae concerns are separated before method selection.
Aesthetic Medicine · Physician-Led Assessment · Istanbul
Aesthetic Medicine
Aesthetic Medicine includes different clinical tasks: muscle activity, volume and contour, skin quality, tissue support, local body applications, scars and stretch marks. The decision begins with anatomy, diagnosis, product or device identity and a realistic aim.
These routes do not form a package or ranking. Injectables, implants, body treatments and scar or striae approaches retain separate indications, evidence and safety pathways.
Physician-Led Orientation
Four levels before method selection
A reasoned sequence begins with the clinical question.
Online review can organise the question. Final suitability follows from in-person examination, the exact product or device and an individual risk–benefit assessment.
02
Anatomy and tissue
Vessels, nerves, glands, muscle, skin, fat and previous procedures shape suitability and risk.
03
Product or device
Composition, manufacture, authorisation, intended route and exact target are checked for the proposed intervention.
04
Evidence and exit
Product-specific evidence, alternatives, follow-up and reasons to withhold or stop are documented.
Aesthetic Medicine · 01–03
Similar delivery labels can hide different products and tissues
Skin-directed injections and subcutaneous body treatment stay distinct.
Mesotherapy, skin boosters and injection lipolysis may all involve needles, but formulation, tissue target, authorisation and anatomical risk are not interchangeable.
01Skin-directed microinjections
Aesthetic Mesotherapy
Formula-, manufacturer- and route-specific review of local skin microinjections; not a standard cocktail.
Decision boundaryNo unnamed mixture or personal injection recipe.
Open Aesthetic Mesotherapy02Skin-quality injectables
Skin Quality and Skin Boosters
Product-specific separation of intradermal HA, bioremodelling descriptions, classic fillers and other injectables.
Decision boundaryCross-linking, rheology and target tissue remain visible.
Open Skin Quality and Skin Boosters03Body and subcutaneous tissue
Injection Lipolysis and Body Contouring
Medicine-, licensed-area- and anatomy-specific assessment of a defined subcutaneous fat question.
Decision boundarySubmental evidence is not transferred across the body.
Open Injection Lipolysis and Body ContouringAesthetic Medicine · 04–06
Morphology, stage and muscle function require separate assessment
Scars, stretch marks and muscle activity are different clinical questions.
A scar or striae pathway begins with classification and healing risk; botulinum toxin begins with a prescription product, authorised indication and observed muscle function.
01Scar morphology
Scar Treatment
Staged planning by scar type, maturity, cause, anatomy, symptoms and realistic clinical target.
Decision boundaryNo single method fits every scar or erases scar tissue.
Open Scar Treatment02Striae and skin structure
Stretch Mark Treatment
Assessment of early and mature striae, skin type, cause, pigment risk and partial colour or texture aims.
Decision boundaryComplete disappearance or return to previous skin is not promised.
Open Stretch Mark Treatment03Muscle activity
Botulinum Toxin Treatment
Product-, toxin-, authorised-indication- and muscle-specific review with non-interchangeable units.
Decision boundaryNo cross-brand unit conversion or public muscle protocol.
Open Botulinum Toxin TreatmentAesthetic Medicine · 07–09
Volume, tissue response and mechanical support are not equivalents
Fillers, biostimulators and threads retain different material limits.
HA gel behaviour, particulate implants and thread-based support have different targets, reversibility limits, delayed risks and surgical alternatives.
01Volume and contour
Hyaluronic Acid Fillers
Gel, cross-linking, rheology, anatomical target and vascular-safety planning remain connected.
Decision boundaryNot every HA gel is interchangeable or completely reversible.
Open Hyaluronic Acid Fillers02Tissue-response implants
Collagen Biostimulators
PLLA, CaHA and other preparations are separated by material, carrier, preparation, tissue target and delayed risk.
Decision boundaryCollagen response and removability are not guaranteed.
Open Collagen Biostimulators03Mechanical tissue support
Thread Lift
Thread material, design, tissue path and limited mechanical aim are compared with surgical alternatives.
Decision boundaryThread placement is not equivalent to a surgical facelift.
Open Thread LiftQuality and Safety Framework
Four binding principles
Premium care means clearer selection, boundaries and follow-up.
Advertising language and package logic are replaced by product traceability, anatomy, proportionate alternatives and documented review.
01
Anatomy before trend
The clinical finding and vulnerable structures guide whether a method belongs in the discussion.
02
Identity before category
A market label never replaces product, device, material, batch, route or authorisation.
03
Risk before package
Time-critical and delayed complications, alternatives and a no-treatment option remain visible.
04
Review before repetition
Early reactions, later endpoints and stop criteria are assessed before another intervention.
Bağdat Caddesi · Istanbul
International patient pathway
Travel, examination and follow-up form one medical process.
The in-person appointment remains the decision point. Product records, early safety, return travel and local medical access are considered before treatment.
- 01Before travel
Organise the question
Previous procedures, medicines, relevant history and comparable photographs prepare discussion without confirming suitability.
- 02In Istanbul
Examine in person
Anatomy, tissue, diagnosis, product or device, risks and alternatives are reviewed together.
- 03Treatment day
Keep traceability
Any intervention retains exact material, product or device, batch where relevant, region, route and observations.
- 04After return
Make follow-up workable
Expected reactions, stop criteria, local medical access and the later endpoint are arranged before departure.
The Doctor Aslan Approach
Medical responsibility before method selection
The method follows the tissue question, not the other way round.
Doctor Aslan's approach keeps anatomy, product identity, evidence, limitations and alternatives in the same decision. Premium care means clearer boundaries, not more procedures.
Separate the tasks
Muscle, volume, skin, fat, scars and tissue support are not merged into one aesthetic package.
Audit the intervention
Composition, manufacture, authorisation, route and target remain traceable.
Plan for harm
Immediate, delayed and time-critical adverse effects have a documented response route.
Accept no treatment
If benefit, evidence or safety is insufficient, withholding treatment is a clinical decision.
Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information; no personal diagnosis, injection protocol or outcome guarantee
Frequently Asked Questions
Short and clear
Questions commonly asked before a decision.
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
01What is Aesthetic Medicine?+
Aesthetic Medicine is described on this page as one defined clinical route. Its role, limits and possible alternatives are considered together rather than treating the method name as a personal recommendation.
02Who may be assessed for Aesthetic Medicine?+
Suitability depends on the medical question, history, examination, the exact product or device where relevant, realistic aims and an individual benefit–risk assessment.
03What remains undecided after an online review?+
Diagnosis, definitive suitability, the treatment protocol, product, dose or device settings, expected response and the option not to proceed remain subject to personal medical assessment.
04How are treatment and follow-up in Istanbul planned?+
The in-person examination remains the decision point. Expected early reactions, warning signs, the direct contact route, return travel and access to appropriate local medical care are discussed before treatment.
Next Step
Define the question · identify the intervention · compare alternatives